Skip to main content

Site notifications

AusPAR: Tozinameran (mRNA Covid 19 vaccine)

Australian Public Assessment Report
Device/Product Name
Comirnaty
Active ingredients
Tozinameran (mRNA Covid 19 vaccine)
AusPAR Date
Published
Submission Number
PM-2021-05012-1-2
Submission Type
Extension of indications; change to formulation (excipients)
Decision
Approved

Help us improve the Therapeutic Goods Administration site